News
FDA approves brentuximab vedotin for primary cutaneous anaplastic large cell lymphoma
Approval was based on a 56% objective response rate for brentuximab vedotin vs. 12% for physician’s choice of methotrexate or bexarotene in a...
News
Adjunctive minocycline for schizophrenia found beneficial
Antimicrobial might reduce neuroinflammation, dampen activated microglia, and enhance glutamate neurotransmitters.
News
Late-Breaking Science preview: Wednesday, Nov. 15
Wednesday at AHA is worth sticking around for, if you like innovation.
News
AML candidate drug back in the pipeline
Phase 1 trials of UCART123 were halted in September but the FDA has given clearance for research to continue, with conditions.
News
Late-Breaking Science preview: Tuesday, Nov. 14
Antithrombotic therapy is the focus of the Late-Breaking Science 5 presentation.
News
Psych evaluation identifies bariatric surgery patients who do less well
Bariatric surgery is an emotional ordeal and psychological testing prior to the event can flag those who may need more support once the deed is...
News
Pregnant women’s access to vaccination website, social media improved infants’ up-to-date immunizations
More vaccine-hesitant women visited the website than did nonhesitant women.
News
Late-Breaking Science preview: Monday, Nov. 13
Monday at AHA is packed with three Late-Breaking Science sessions, with many presentations providing new insights into blockbuster megatrials.
Opinion
Medical malpractice and the hospitalist: Reasons for optimism
The most common types of malpractice allegations made against hospitalists were related to medical treatment, diagnosis, and medications.
News
Late-Breaking Science preview: Sunday, Nov. 12
AHA’s top abstract picks for Sunday focus on periprocedural dilemmas.